Recent

% | $
Quotes you view appear here for quick access.

Delcath Systems, Inc. Message Board

  • okiedivot okiedivot Jan 31, 2013 11:39 AM Flag

    Feuerstein - Ratain Rule

    I will admit upfront that AF drives me nuts with his articles. Problem is, AF is 21 for 21 when (and only when) he sticks to the Feuerstein-Ratain Rule. If you don't have this rule committed to memory, it is easy to find my searching for the exact phrase. As late as Jan 20th, there were articles slamming the rule and trumpeting the end of the rules perfect score because CLSN was going explode and stay on top. That isn't looking like a good call.

    Short version: Company needs $300 million market cap BEFORE releasing final trial results. Precisely - companies with market cap under $300 million are 0 for 21 on their trial results. Of course, a lot of this hinges on what date is used to determine ""several months before trial data released". If one uses March, 2012, both KERX and DCTH qualify. If one uses November, 2012, they don't.

    Being over $1 billion in market cap gets you a 77% chance of phase III success.

    It's always something.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
DCTH
0.4003-0.0097(-2.37%)Aug 28 4:00 PMEDT